Ann H. Partridge mainly focuses on Breast cancer, Internal medicine, Gynecology, Oncology and Cancer. Her Breast cancer research integrates issues from Clinical trial, Disease and Obstetrics. Her work investigates the relationship between Internal medicine and topics such as Surgery that intersect with problems in Trastuzumab.
Her Gynecology study incorporates themes from Fertility preservation, Fertility, Cohort study, Randomized controlled trial and Menopause. Her research integrates issues of Chemotherapy, Metastatic breast cancer, Amenorrhea, Pregnancy rate and Hazard ratio in her study of Oncology. Her studies deal with areas such as Guideline, Pill, Alternative medicine, Proportional hazards model and Physical exercise as well as Cancer.
Ann H. Partridge spends much of her time researching Breast cancer, Internal medicine, Oncology, Cancer and Gynecology. Her Breast cancer research is multidisciplinary, relying on both Fertility, Disease, Obstetrics, Stage and Prospective cohort study. Her Fertility study integrates concerns from other disciplines, such as Psychosocial and Infertility.
As part of one scientific family, Ann H. Partridge deals mainly with the area of Oncology, narrowing it down to issues related to the Surgery, and often Mastectomy. Her Cancer course of study focuses on Quality of life and Physical therapy. Her biological study spans a wide range of topics, including Young adult, Odds ratio, Menopause and Cohort study.
Ann H. Partridge mostly deals with Breast cancer, Internal medicine, Oncology, Cancer and Prospective cohort study. The various areas that she examines in her Breast cancer study include Psychosocial, Quality of life, Anxiety, Stage and Depression. Her research in Quality of life tackles topics such as Mastectomy which are related to areas like Breast surgery and Cohort study.
Her work on Adjuvant as part of her general Oncology study is frequently connected to In patient, thereby bridging the divide between different branches of science. Her research investigates the connection between Cancer and topics such as Confidence interval that intersect with problems in Odds ratio and Fertility. Her Prospective cohort study research incorporates elements of Young adult, Estrogen and Survivorship curve.
Ann H. Partridge focuses on Internal medicine, Breast cancer, Oncology, Prospective cohort study and Chemotherapy. Ann H. Partridge works in the field of Breast cancer, focusing on Breast surgery in particular. In Breast surgery, she works on issues like Surgery, which are connected to Mastectomy and Cohort study.
The Oncology study combines topics in areas such as Tamoxifen, Metastatic breast cancer, HER2 negative and Endocrine system. Her Chemotherapy research is multidisciplinary, incorporating perspectives in Triple negative, Surgical oncology, Gastroenterology and Breast disease. Ann H. Partridge interconnects Acupuncture and Neuropathic pain in the investigation of issues within Cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch;E P Winer;A S Coates;R D Gelber.
Annals of Oncology (2013)
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
Stephanie J. Lee;Leslie R. Schover;Ann H. Partridge;Pasquale Patrizio.
Journal of Clinical Oncology (2006)
Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Alison W. Loren;Pamela B. Mangu;Lindsay Nohr Beck;Lawrence Brennan.
Journal of Clinical Oncology (2013)
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant.
Annals of Oncology (2017)
Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.
Kutluk Oktay;Brittany E. Harvey;Ann H. Partridge;Gwendolyn P. Quinn.
Journal of Clinical Oncology (2018)
Web-based survey of fertility issues in Young women with breast cancer
Ann H. Partridge;Shari Gelber;Jeffrey Peppercorn;Ebonie Sampson.
Journal of Clinical Oncology (2004)
Adherence to Therapy With Oral Antineoplastic Agents
Ann H. Partridge;Jerry Avorn;Philip S. Wang;Eric P. Winer.
Journal of the National Cancer Institute (2002)
Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer
Ann H. Partridge;Philip S. Wang;Eric P. Winer;Jerry Avorn.
Journal of Clinical Oncology (2003)
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.
Sara M. Tolaney;William T. Barry;Chau T. Dang;Denise A. Yardley.
The New England Journal of Medicine (2015)
Patient adherence and persistence with oral anticancer treatment
Kathryn Ruddy;Erica Mayer;Ann Partridge.
CA: A Cancer Journal for Clinicians (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: